WH Seeks To Hike Domestic APIs, Give Critical Drugs Price Preferences

By Kelly Lienhard / July 28, 2021 at 2:29 PM
The White House Office of Management and Budget unveiled a proposed rule Wednesday (July 27) that aims to advance the administration’s goal of returning critical supply chains, including those for drugs and medical supplies, to the United States by increasing production of active pharmaceutical ingredients and offering price preferences for domestic products. White House officials said the proposed rule is just the first step the administration plans to take in strengthening domestic manufacturing. Under the proposed rule, at least 60%...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.